Trials / Recruiting
RecruitingNCT06654895
Multicenter Symphony IL-6 Monitoring Sepsis ICU Validation Study
- Status
- Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 700 (estimated)
- Sponsor
- Bluejay Diagnostics, Inc. · Industry
- Sex
- All
- Age
- 22 Years
- Healthy volunteers
- Not accepted
Summary
The primary objective of this study is to validate a pre-defined IL-6 concentration cutoff that predicts 28-day mortality in patients who are admitted or are intended to be admitted to the ICU diagnosed with sepsis or septic shock.
Conditions
Timeline
- Start date
- 2024-11-12
- Primary completion
- 2026-08-30
- Completion
- 2026-08-30
- First posted
- 2024-10-23
- Last updated
- 2026-02-03
Locations
5 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT06654895. Inclusion in this directory is not an endorsement.